Literature DB >> 19281265

Why amantadine loses its function in influenza m2 mutants: MD simulations.

Chittima Laohpongspaisan1, Thanyada Rungrotmongkol, Pathumwadee Intharathep, Maturos Malaisree, Panita Decha, Ornjira Aruksakunwong, Pornthep Sompornpisut, Supot Hannongbua.   

Abstract

Molecular dynamics simulations of the drug-resistant M2 mutants, A30T, S31N, and L26I, were carried out to investigate the inhibition of M2 activity using amantadine (AMT). The closed and open channel conformations were examined via non- and triply protonated H37. For the nonprotonated state, these mutants exhibited zero water density in the conducting region, and AMT was still bound to the channel pore. Thus, water transport is totally suppressed, similar to the wild-type channel. In contrast, the triply protonated states of the mutants exhibited a different water density and AMT position. A30T and L26I both have a greater water density compared to the wild-type M2, while for the A30T system, AMT is no longer inside the pore. Hydrogen bonding between AMT and H37 crucial for the bioactivity is entirely lost in the open conformation. The elimination of this important interaction of these mutations is responsible for the lost of AMT's function in influenza A M2. This is different for the S31N mutant in which AMT was observed to locate at the pore opening region and bond with V27 instead of S31.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19281265     DOI: 10.1021/ci800267a

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  9 in total

Review 1.  Structural basis for proton conduction and inhibition by the influenza M2 protein.

Authors:  Mei Hong; William F DeGrado
Journal:  Protein Sci       Date:  2012-10-09       Impact factor: 6.725

Review 2.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

3.  Specific binding of adamantane drugs and direction of their polar amines in the pore of the influenza M2 transmembrane domain in lipid bilayers and dodecylphosphocholine micelles determined by NMR spectroscopy.

Authors:  Sarah D Cady; Jun Wang; Yibing Wu; William F DeGrado; Mei Hong
Journal:  J Am Chem Soc       Date:  2011-03-07       Impact factor: 15.419

Review 4.  Structural and dynamic mechanisms for the function and inhibition of the M2 proton channel from influenza A virus.

Authors:  Jun Wang; Jade Xiaoyan Qiu; Cinque Soto; William F DeGrado
Journal:  Curr Opin Struct Biol       Date:  2011-01-17       Impact factor: 6.809

5.  Structural basis for the function and inhibition of an influenza virus proton channel.

Authors:  Amanda L Stouffer; Rudresh Acharya; David Salom; Anna S Levine; Luigi Di Costanzo; Cinque S Soto; Valentina Tereshko; Vikas Nanda; Steven Stayrook; William F DeGrado
Journal:  Nature       Date:  2008-01-31       Impact factor: 49.962

6.  Binding and Proton Blockage by Amantadine Variants of the Influenza M2WT and M2S31N Explained.

Authors:  Christina Tzitzoglaki; Anna Wright; Kathrin Freudenberger; Anja Hoffmann; Ian Tietjen; Ioannis Stylianakis; Felix Kolarov; David Fedida; Michaela Schmidtke; Günter Gauglitz; Timothy A Cross; Antonios Kolocouris
Journal:  J Med Chem       Date:  2017-02-15       Impact factor: 8.039

7.  Study on phylogenetic relationships, variability, and correlated mutations in M2 proteins of influenza virus A.

Authors:  Ly Le; Jacek Leluk
Journal:  PLoS One       Date:  2011-08-02       Impact factor: 3.240

8.  Triple combination antiviral drug (TCAD) composed of amantadine, oseltamivir, and ribavirin impedes the selection of drug-resistant influenza A virus.

Authors:  Justin D Hoopes; Elizabeth M Driebe; Erin Kelley; David M Engelthaler; Paul S Keim; Alan S Perelson; Libin Rong; Gregory T Went; Jack T Nguyen
Journal:  PLoS One       Date:  2011-12-29       Impact factor: 3.240

9.  Discovery of potential M2 channel inhibitors based on the amantadine scaffold via virtual screening and pharmacophore modeling.

Authors:  Linh Tran; Sy Bing Choi; Belal O Al-Najjar; Muhammad Yusuf; Habibah A Wahab; Ly Le
Journal:  Molecules       Date:  2011-12-08       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.